Health-care companies ticked up as deal activity continued.

British drug giant GSK agreed to buy biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline. The deal follows multibillion-dollar tie-up plans from Boston Scientific, Novartis and others.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

01-09-24 1851ET